MyFinsight
Home
Blog
About
Contact
Download
Download image
Short-term investments
$248,478K
Cash and cash
equivalents
$165,596K
Inventory
$54,895K
Prepaid expenses and
other current assets
$42,614K
Accounts receivable, net
$15,594K
Total current assets
$527,177K
Deferred tax assets
$198,149K
Intangible asset, net
$15,250K
Other long-term
assets
$11,307K
Operating lease
right-of-use assets
$9,807K
Property and equipment,
net
$1,943K
Total assets
$763,633K
Total liabilities and
shareholders' equity
$763,633K
Total shareholders'
equity
$567,606K
Total liabilities
$196,027K
Accumulated deficit
-$462,138K
Accumulated other
comprehensive loss
-$25K
Additional paid-in capital
$1,029,748K
Total current
liabilities
$139,184K
Non-current deferred
revenue
$31,811K
Other long-term
liabilities
$18,522K
Non-current operating lease
liabilities
$6,510K
Ordinary shares
value-Common Class A
$12K
Ordinary shares
value-Common Class B1
$4K
Ordinary shares
value-Common Class A1
$4K
Ordinary shares
value-Common Class B
$1K
Accrued collaboration
expenses
$70,015K
Accrued expenses
$42,020K
Other current
liabilities
$22,134K
Operating lease
liabilities
$2,987K
Accounts payable
$2,028K
Back
Back
Balance Sheet
source: myfinsight.com
Kiniksa Pharmaceuticals International, plc (KNSA)
Kiniksa Pharmaceuticals International, plc (KNSA)